Skip to main
ORGS
ORGS logo

Orgenesis (ORGS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Orgenesis (ORGS) Stock

About Orgenesis (ORGS)

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferbe...read more
Market cap$4.6M
Yesterday's volume5.31K
Revenue (TTM)$899K
Avg. daily volume1.91K
EBITDA (TTM)-$24.05M
Open$1
Price / earnings ratio-0.10x
Yesterday's range$0.1 - $1
Debt / equity
52 week range$0 - $5.89
5 year debt / equity
Beta (LTM)1020.23x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio0.07x
Ex-dividend date
Next earningsNov 13, 2024
Dividend payable date

Frequently Asked Questions (FAQ)

As of Oct 13, 2025, the market cap for Orgenesis stock is $4.61M

The current P/E ratio for Orgenesis stock is -0.1

The 52-week high for Orgenesis stock is $5.89. The current Orgenesis stock price $undefined is 100.00% below its 52-week high

The 52-week low for Orgenesis stock is $0.00. The current Orgenesis stock price $undefined has increased 100.00% from its 52-week low

No, the Orgenesis stock does not pay dividends to its shareholders

How to buy Orgenesis stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Orgenesis stock

    Navigate to the Explore page. Then, type Orgenesis into the search bar. When you see Orgenesis stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Orgenesis stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Orgenesis Stock Earnings

The value each ORGS share was expected to gain vs. the value that each ORGS share actually gained.

Orgenesis (ORGS) reported Q3 2023 earnings per share (EPS) of -$4.30, missing estimates of $1 by 530.00%. In the same quarter last year, Orgenesis's earnings per share (EPS) was -$0.50. Orgenesis is expected to release next earnings on 11/13/2024, with an earnings per share (EPS) estimate of $0.

Buy Orgenesis (ORGS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.